1. Home
  2. PHAR vs COUR Comparison

PHAR vs COUR Comparison

Compare PHAR & COUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

N/A

Current Price

$17.10

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo Coursera Inc.

COUR

Coursera Inc.

HOLD

Current Price

$6.52

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHAR
COUR
Founded
1988
2012
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
PHAR
COUR
Price
$17.10
$6.52
Analyst Decision
Strong Buy
Buy
Analyst Count
2
14
Target Price
$38.00
$11.07
AVG Volume (30 Days)
32.4K
6.1M
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.22
EPS
N/A
N/A
Revenue
N/A
$757,500,000.00
Revenue This Year
$27.75
$9.10
Revenue Next Year
$9.39
$6.38
P/E Ratio
$3,041.22
N/A
Revenue Growth
N/A
9.04
52 Week Low
$7.50
$5.47
52 Week High
$21.34
$13.56

Technical Indicators

Market Signals
Indicator
PHAR
COUR
Relative Strength Index (RSI) 48.93 52.62
Support Level $16.35 $5.47
Resistance Level $17.08 $6.38
Average True Range (ATR) 0.57 0.33
MACD 0.06 0.10
Stochastic Oscillator 77.74 84.95

Price Performance

Historical Comparison
PHAR
COUR

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through three reporting segments: Consumer, Enterprise, and Degrees. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

Share on Social Networks: